82 FR 58654 - Importer of Controlled Substances Application: VHG Labs DBA LGC Standard Warehouse
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 82, Issue 238 (December 13, 2017)
Drug Enforcement Administration
Federal Register Volume 82, Issue 238 (December 13, 2017)
| Page Range | 58654-58657 | |
| FR Document | 2017-26855 |
[Federal Register Volume 82, Number 238 (Wednesday, December 13, 2017)] [Notices] [Pages 58654-58657] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-26855] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: VHG Labs DBA LGC Standard Warehouse ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 12, 2018. Such persons may also file a written request for a hearing on the application on or before January 12, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix of subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on April 4, 2017, VHG LABS DBA LGC Standards Warehouse, 3 Perimeter Road, Manchester, New Hampshire 03103 applied to be registered as an importer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ 3-Fluoro-N-methylcathinone (3-FMC)....... 1233 I Cathinone................................ 1235 I Methcathinone............................ 1237 I 4-Fluoro-N-methylcathinone (4-FMC)....... 1238 I Pentedrone ([alpha]- 1246 I methylaminovalerophenone). Mephedrone (4-Methyl-N-methylcathinone).. 1248 I 4-Methyl-N-ethylcathinone (4-MEC)........ 1249 I Naphyrone................................ 1258 I N-Ethylamphetamine....................... 1475 I N,N-Dimethylamphetamine.................. 1480 I Fenethylline............................. 1503 I 4-Methylaminorex (cis isomer)............ 1590 I Methaqualone............................. 2565 I Mecloqualone............................. 2572 I JWH-250 (1-Pentyl-3-(2- 6250 I methoxyphenylacetyl) indole). SR-18 (Also known as RCS-8) (1- 7008 I Cyclohexylethyl-3-(2- methoxyphenylacetyl) indole). 5-Flouro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I pentyl)1H-indol-3-yl](2,2,3,3- tetramethylcyclopropyl)methanone. AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I oxobutan-2-yl)-1-(4-fluorobenzyl)-1H- indazole-3-carboxamide). JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).. 7019 I ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I oxobutan-2-yl)-1-pentyl-1H-indazole-3- carboxamide). APINACA and AKB48 N-(1-Adamantyl)-1- 7048 I pentyl-1H-indazole-3-carboxamide. JWH-081 (1-Pentyl-3-(1-(4- 7081 I methoxynaphthoyl) indole). SR-19 (Also known as RCS-4) (1-Pentyl-3- 7104 I [(4-methoxy)-benzoyl] indole. JWH-018 (also known as AM678) (1-Pentyl-3- 7118 I (1-naphthoyl)indole). JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I naphthoyl) indole). UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I tetramethylcyclopropyl)methanone. JWH-073 (1-Butyl-3-(1-naphthoyl)indole).. 7173 I JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I naphthoyl)indole). AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I naphthoyl) indole). JWH-203 (1-Pentyl-3-(2- 7203 I chlorophenylacetyl) indole). PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- 7222 I carboxylate). 5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I fluoropentyl)-1H-indole-3-carboxylate). Alpha-ethyltryptamine.................... 7249 I Ibogaine................................. 7260 I CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I [(1R,3S)-3-hydroxycyclohexyl-phenol). CP-47,497 C8 Homologue (5-(1,1- 7298 I Dimethyloctyl)-2-[(1R,3S)3- hydroxycyclohexyl-phenol). [[Page 58655]] Lysergic acid diethylamide............... 7315 I 2,5-Dimethoxy-4-(n)- 7348 I propylthiophenethylamine (2C-T-7). Marihuana................................ 7360 I Parahexyl................................ 7374 I Mescaline................................ 7381 I 2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I ethanamine (2C-T-2 ). 3,4,5-Trimethoxyamphetamine.............. 7390 I 4-Bromo-2,5-dimethoxyamphetamine......... 7391 I 4-Bromo-2,5-dimethoxyphenethylamine...... 7392 I 4-Methyl-2,5-dimethoxyamphetamine........ 7395 I 2,5-Dimethoxyamphetamine................. 7396 I JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I naphthoyl) indole). 2,5-Dimethoxy-4-ethylamphetamine......... 7399 I 3,4-Methylenedioxyamphetamine............ 7400 I 5-Methoxy-3,4-methylenedioxyamphetamine.. 7401 I N-Hydroxy-3,4-methylenedioxyamphetamine.. 7402 I 3,4-Methylenedioxy-N-ethylamphetamine.... 7404 I 3,4-Methylenedioxymethamphetamine........ 7405 I 4-Methoxyamphetamine..................... 7411 I Peyote................................... 7415 I 5-Methoxy-N-N-dimethyltryptamine......... 7431 I Alpha-methyltryptamine................... 7432 I Bufotenine............................... 7433 I Diethyltryptamine........................ 7434 I Dimethyltryptamine....................... 7435 I Psilocybin............................... 7437 I Psilocyn................................. 7438 I 5-Methoxy-N,N-diisopropyltryptamine...... 7439 I N-Ethyl-1-phenylcyclohexylamine.......... 7455 I 1-(1-Phenylcyclohexyl)pyrrolidine........ 7458 I 1-[1-(2-Thienyl)cyclohexyl]piperidine.... 7470 I 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine... 7473 I N-Ethyl-3-piperidyl benzilate............ 7482 I N-Methyl-3-piperidyl benzilate........... 7484 I N-Benzylpiperazine....................... 7493 I 4-Methyl-alphapyrrolidinopropiophenone (4- 7498 I MePPP). 2-(2,5-Dimethoxy-4-methylphenyl) 7508 I ethanamine (2C-D). 2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I ethanamine (2C-E ). 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) 7517 I 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine 7518 I (2C-I). 2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I ethanamine (2C-C). 2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I ethanamine (2C-N). 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) 7532 I ethanamine (2C-T-4 ). MDPV (3,4-Methylenedioxypyrovalerone).... 7535 I 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- 7536 I methoxybenzyl) ethanamine (25B-NBOMe). 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- 7537 I methoxybenzyl) ethanamine (25C-NBOMe). Methylone (3,4-Methylenedioxy-N- 7540 I methylcathinone). Butylone................................. 7541 I Pentylone................................ 7542 I alpha-pyrrolidinopentiophenone ([alpha]- 7545 I PVP). alpha-pyrrolidinobutiophenone ([alpha]- 7546 I PBP). AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I iodobenzoyl) indole). Acetyldihydrocodeine..................... 9051 I Benzylmorphine........................... 9052 I Codeine-N-oxide.......................... 9053 I Cyprenorphine............................ 9054 I Desomorphine............................. 9055 I Etorphine (except HCl)................... 9056 I Codeine methylbromide.................... 9070 I Dihydromorphine.......................... 9145 I Difenoxin................................ 9168 I Heroin................................... 9200 I Hydromorphinol........................... 9301 I Methyldesorphine......................... 9302 I Methyldihydromorphine.................... 9304 I Morphine methylbromide................... 9305 I Morphine methylsulfonate................. 9306 I Morphine-N-oxide......................... 9307 I Myrophine................................ 9308 I Nicocodeine.............................. 9309 I Nicomorphine............................. 9312 I Normorphine.............................. 9313 I Pholcodine............................... 9314 I Thebacon................................. 9315 I [[Page 58656]] Acetorphine.............................. 9319 I Drotebanol............................... 9335 I Acetylmethadol........................... 9601 I Allylprodine............................. 9602 I Alphacetylmethadol except levo- 9603 I alphacetylmethadol. Alphameprodine........................... 9604 I Alphamethadol............................ 9605 I Benzethidine............................. 9606 I Betacetylmethadol........................ 9607 I Betameprodine............................ 9608 I Betamethadol............................. 9609 I Betaprodine.............................. 9611 I Clonitazene.............................. 9612 I Dextromoramide........................... 9613 I Diampromide.............................. 9615 I Dimenoxadol.............................. 9617 I Dimepheptanol............................ 9618 I Dimethylthiambutene...................... 9619 I Dioxaphetyl butyrate..................... 9621 I Dipipanone............................... 9622 I Ethylmethylthiambutene................... 9623 I Etonitazene.............................. 9624 I Etoxeridine.............................. 9625 I Furethidine.............................. 9626 I Ketobemidone............................. 9628 I Levomoramide............................. 9629 I Levophenacylmorphan...................... 9631 I Morpheridine............................. 9632 I Noracymethadol........................... 9633 I Normethadone............................. 9635 I Norpipanone.............................. 9636 I Phenadoxone.............................. 9637 I Phenoperidine............................ 9641 I Piritramide.............................. 9642 I Proheptazine............................. 9643 I Properidine.............................. 9644 I Racemoramide............................. 9645 I Trimeperidine............................ 9646 I Phenomorphan............................. 9647 I Propiram................................. 9649 I 1-Methyl-4-phenyl-4-propionoxypiperidine. 9661 I 1-(2-Phenylethyl)-4-phenyl-4- 9663 I acetoxypiperidine. Tilidine................................. 9750 I Para-Fluorofentanyl...................... 9812 I 3-Methylfentanyl......................... 9813 I Alpha-methylfentanyl..................... 9814 I Acetyl-alpha-methylfentanyl.............. 9815 I Beta-hydroxyfentanyl..................... 9830 I Beta-hydroxy-3-methylfentanyl............ 9831 I Alpha-methylthiofentanyl................. 9832 I 3-Methylthiofentanyl..................... 9833 I Thiofentanyl............................. 9835 I Methamphetamine.......................... 1105 II Phenmetrazine............................ 1631 II Amobarbital.............................. 2125 II Pentobarbital............................ 2270 II Secobarbital............................. 2315 II Glutethimide............................. 2550 II Nabilone................................. 7379 II 1-Phenylcyclohexylamine.................. 7460 II Phencyclidine............................ 7471 II Phenylacetone............................ 8501 II 1-Piperidinocyclohexanecarbonitrile...... 8603 II Alphaprodine............................. 9010 II Anileridine.............................. 9020 II Etorphine HCl............................ 9059 II Dihydrocodeine........................... 9120 II Diphenoxylate............................ 9170 II Ecgonine................................. 9180 II Ethylmorphine............................ 9190 II Levomethorphan........................... 9210 II Levorphanol.............................. 9220 II Isomethadone............................. 9226 II Meperidine............................... 9230 II [[Page 58657]] Meperidine intermediate-A................ 9232 II Meperidine intermediate-B................ 9233 II Meperidine intermediate-C................ 9234 II Metazocine............................... 9240 II Metopon.................................. 9260 II Dextropropoxyphene, bulk (non-dosage 9273 II forms). Dihydroetorphine......................... 9334 II Levo-alphacetylmethadol.................. 9648 II Noroxymorphone........................... 9668 II Phenazocine.............................. 9715 II Piminodine............................... 9730 II Racemethorphan........................... 9732 II Racemorphan.............................. 9733 II Alfentanil............................... 9737 II Remifentanil............................. 9739 II Sufentanil............................... 9740 II Carfentanil.............................. 9743 II Tapentadol............................... 9780 II Bezitramide.............................. 9800 II Moramide-intermediate.................... 9802 II ------------------------------------------------------------------------ The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Placement of these drug codes onto the company's registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale. Dated: December 7, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017-26855 Filed 12-12-17; 8:45 am] BILLING CODE 4410-09-P
![58654 Federal Register / Vol. 82, No. 238 / Wednesday, December 13, 2017 / Notices
project remains open, and CHEDE–VII DEPARTMENT OF JUSTICE Drive, Springfield, Virginia 22152; and
intends to file additional written (2) Drug Enforcement Administration,
notifications disclosing all changes in Drug Enforcement Administration Attn: DEA Federal Register
membership. Representative/DRW, 8701 Morrissette
[Docket No. DEA–392]
On January 6, 2016, CHEDE–VII filed Drive, Springfield, Virginia 22152.
its original notification pursuant to Importer of Controlled Substances SUPPLEMENTARY INFORMATION: The
Section 6(a) of the Act. The Department Application: VHG Labs DBA LGC Attorney General has delegated his
of Justice published a notice in the Standard Warehouse authority under the Controlled
Federal Register pursuant to Section Substances Act to the Administrator of
ACTION: Notice of application. the Drug Enforcement Administration
6(b) of the Act on February 2, 2016, (81
(DEA), 28 CFR 0.100(b). Authority to
FR 5484). DATES: Registered bulk manufacturers of exercise all necessary functions with
The last notification was filed with the affected basic classes and applicants respect to the promulgation and
the Department on February 13, 2017. A therefore, may file written comments on implementation of 21 CFR part 1301,
notice was published in the Federal or objections to the issuance of the incident to the registration of
Register pursuant to section 6(b) of the proposed registration on or before manufacturers, distributors, dispensers,
Act on March 27, 2017, (82 FR 15239). January 12, 2018. Such persons may importers, and exporters of controlled
also file a written request for a hearing substances (other than final orders in
Patricia A. Brink, on the application on or before January connection with suspension, denial, or
Director of Civil Enforcement, Antitrust 12, 2018. revocation of registration) has been
Division. ADDRESSES: Written comments should redelegated to the Assistant
[FR Doc. 2017–26890 Filed 12–12–17; 8:45 am] be sent to: Drug Enforcement Administrator of the DEA Diversion
BILLING CODE P Administration, Attention: DEA Federal Control Division (‘‘Assistant
Register Representative/DRW, 8701 Administrator’’) pursuant to section 7 of
Morrissette Drive, Springfield, Virginia 28 CFR part 0, appendix of subpart R.
22152. All requests for hearing must be In accordance with 21 CFR
sent to: Drug Enforcement 1301.34(a), this is notice that on April
Administration, Attn: Administrator, 4, 2017, VHG LABS DBA LGC Standards
8701 Morrissette Drive, Springfield, Warehouse, 3 Perimeter Road,
Virginia 22152. All request for hearing Manchester, New Hampshire 03103
should also be sent to: (1) Drug applied to be registered as an importer
Enforcement Administration, Attn: of the following basic classes of
Hearing Clerk/LJ, 8701 Morrissette controlled substances:
Controlled substance Drug code Schedule
3-Fluoro-N-methylcathinone (3-FMC) .............................................................................................................................. 1233 I
Cathinone ........................................................................................................................................................................ 1235 I
Methcathinone ................................................................................................................................................................. 1237 I
4-Fluoro-N-methylcathinone (4-FMC) .............................................................................................................................. 1238 I
Pentedrone (a-methylaminovalerophenone) ................................................................................................................... 1246 I
Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I
4-Methyl-N-ethylcathinone (4-MEC) ................................................................................................................................ 1249 I
Naphyrone ....................................................................................................................................................................... 1258 I
N-Ethylamphetamine ....................................................................................................................................................... 1475 I
N,N-Dimethylamphetamine .............................................................................................................................................. 1480 I
Fenethylline ..................................................................................................................................................................... 1503 I
4-Methylaminorex (cis isomer) ........................................................................................................................................ 1590 I
Methaqualone .................................................................................................................................................................. 2565 I
Mecloqualone .................................................................................................................................................................. 2572 I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ................................................................................................... 6250 I
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................. 7008 I
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ................. 7011 I
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ...................... 7012 I
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ....................................................................................................................... 7019 I
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................. 7035 I
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .............................................................. 7048 I
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ................................................................................................... 7081 I
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ...................................................................... 7104 I
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. 7118 I
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ...................................................................................................... 7122 I
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .................................................................. 7144 I
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ........................................................................................................................ 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ........................................................................................... 7200 I
sradovich on DSK3GMQ082PROD with NOTICES
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... 7201 I
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... 7203 I
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .................................................................................................. 7222 I
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .............................................................................. 7225 I
Alpha-ethyltryptamine ...................................................................................................................................................... 7249 I
Ibogaine ........................................................................................................................................................................... 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................. 7297 I
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ........................................... 7298 I
VerDate Sep<11>2014 18:53 Dec 12, 2017 Jkt 244001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM 13DEN1](https://thefederalregister.org/doc/82_FR_58892/page/1.svg)
![Federal Register / Vol. 82, No. 238 / Wednesday, December 13, 2017 / Notices 58655
Controlled substance Drug code Schedule
Lysergic acid diethylamide .............................................................................................................................................. 7315 I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) ................................................................................................ 7348 I
Marihuana ........................................................................................................................................................................ 7360 I
Parahexyl ......................................................................................................................................................................... 7374 I
Mescaline ......................................................................................................................................................................... 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 ) ............................................................................................ 7385 I
3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 7390 I
4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 7391 I
4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 7392 I
4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 7395 I
2,5-Dimethoxyamphetamine ............................................................................................................................................ 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 7398 I
2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................ 7399 I
3,4-Methylenedioxyamphetamine .................................................................................................................................... 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7402 I
3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 7404 I
3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I
4-Methoxyamphetamine .................................................................................................................................................. 7411 I
Peyote .............................................................................................................................................................................. 7415 I
5-Methoxy-N-N-dimethyltryptamine ................................................................................................................................. 7431 I
Alpha-methyltryptamine ................................................................................................................................................... 7432 I
Bufotenine ........................................................................................................................................................................ 7433 I
Diethyltryptamine ............................................................................................................................................................. 7434 I
Dimethyltryptamine .......................................................................................................................................................... 7435 I
Psilocybin ......................................................................................................................................................................... 7437 I
Psilocyn ........................................................................................................................................................................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. 7439 I
N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... 7470 I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine .............................................................................................................................. 7473 I
N-Ethyl-3-piperidyl benzilate ............................................................................................................................................ 7482 I
N-Methyl-3-piperidyl benzilate ......................................................................................................................................... 7484 I
N-Benzylpiperazine .......................................................................................................................................................... 7493 I
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ..................................................................................................... 7498 I
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) .................................................................................................. 7508 I
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ) .................................................................................................... 7509 I
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) ................................................................................................................. 7517 I
2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) ........................................................................................................ 7518 I
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) ................................................................................................... 7519 I
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) ..................................................................................................... 7521 I
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4 ) .................................................................................... 7532 I
MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 7535 I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) ..................................................... 7536 I
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) ..................................................... 7537 I
Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... 7540 I
Butylone ........................................................................................................................................................................... 7541 I
Pentylone ......................................................................................................................................................................... 7542 I
alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................ 7545 I
alpha-pyrrolidinobutiophenone (a-PBP) .......................................................................................................................... 7546 I
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) .................................................................................................... 7694 I
Acetyldihydrocodeine ....................................................................................................................................................... 9051 I
Benzylmorphine ............................................................................................................................................................... 9052 I
Codeine-N-oxide .............................................................................................................................................................. 9053 I
Cyprenorphine ................................................................................................................................................................. 9054 I
Desomorphine ................................................................................................................................................................. 9055 I
Etorphine (except HCl) .................................................................................................................................................... 9056 I
Codeine methylbromide ................................................................................................................................................... 9070 I
Dihydromorphine ............................................................................................................................................................. 9145 I
Difenoxin .......................................................................................................................................................................... 9168 I
Heroin .............................................................................................................................................................................. 9200 I
Hydromorphinol ............................................................................................................................................................... 9301 I
Methyldesorphine ............................................................................................................................................................ 9302 I
Methyldihydromorphine ................................................................................................................................................... 9304 I
Morphine methylbromide ................................................................................................................................................. 9305 I
sradovich on DSK3GMQ082PROD with NOTICES
Morphine methylsulfonate ............................................................................................................................................... 9306 I
Morphine-N-oxide ............................................................................................................................................................ 9307 I
Myrophine ........................................................................................................................................................................ 9308 I
Nicocodeine ..................................................................................................................................................................... 9309 I
Nicomorphine ................................................................................................................................................................... 9312 I
Normorphine .................................................................................................................................................................... 9313 I
Pholcodine ....................................................................................................................................................................... 9314 I
Thebacon ......................................................................................................................................................................... 9315 I
VerDate Sep<11>2014 18:53 Dec 12, 2017 Jkt 244001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM 13DEN1](https://thefederalregister.org/doc/82_FR_58892/page/2.svg)
![Federal Register / Vol. 82, No. 238 / Wednesday, December 13, 2017 / Notices 58657
Controlled substance Drug code Schedule
Meperidine intermediate-A .............................................................................................................................................. 9232 II
Meperidine intermediate-B .............................................................................................................................................. 9233 II
Meperidine intermediate-C .............................................................................................................................................. 9234 II
Metazocine ...................................................................................................................................................................... 9240 II
Metopon ........................................................................................................................................................................... 9260 II
Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. 9273 II
Dihydroetorphine ............................................................................................................................................................. 9334 II
Levo-alphacetylmethadol ................................................................................................................................................. 9648 II
Noroxymorphone ............................................................................................................................................................. 9668 II
Phenazocine .................................................................................................................................................................... 9715 II
Piminodine ....................................................................................................................................................................... 9730 II
Racemethorphan ............................................................................................................................................................. 9732 II
Racemorphan .................................................................................................................................................................. 9733 II
Alfentanil .......................................................................................................................................................................... 9737 II
Remifentanil ..................................................................................................................................................................... 9739 II
Sufentanil ......................................................................................................................................................................... 9740 II
Carfentanil ....................................................................................................................................................................... 9743 II
Tapentadol ....................................................................................................................................................................... 9780 II
Bezitramide ...................................................................................................................................................................... 9800 II
Moramide-intermediate .................................................................................................................................................... 9802 II
The company plans to import Combined Licenses (COL), NPF–91 and adams.html. To begin the search, select
analytical reference standards for NPF–92, respectively. The COLs were ‘‘ADAMS Public Documents’’ and then
distribution to its customers for research issued to Southern Nuclear Operating select ‘‘Begin Web-based ADAMS
and analytical purposes. Placement of Company, Inc. (SNC), and Georgia Search.’’ For problems with ADAMS,
these drug codes onto the company’s Power Company, Oglethorpe Power please contact the NRC’s Public
registration does not translate into Corporation, MEAG Power SPVM, LLC, Document Room (PDR) reference staff at
automatic approval of subsequent MEAG Power SPVJ, LLC, MEAG Power 1–800–397–4209, 301–415–4737, or by
permit applications to import controlled SPVP, LLC, Authority of Georgia, and email to pdr.resource@nrc.gov. The
substances. Approval of permit the City of Dalton, Georgia (the ADAMS accession number for each
applications will occur only when the licensee); for construction and operation document referenced (if it is available in
registrant’s business activity is of the Vogtle Electric Generating Plant ADAMS) is provided the first time that
consistent with what is authorized (VEGP) Units 3 and 4, located in Burke it is mentioned in this document. The
under 21 U.S.C. 952(a)(2). Authorization County, Georgia. request for the amendment and
will not extend to the import of FDA The granting of the exemption allows exemption was submitted by letter
approved or non-approved finished the changes to Tier 1 information asked dated March 2, 2017, and supplemented
dosage forms for commercial sale. for in the amendment. Because the by letter dated July 28, 2017, (ADAMS
Dated: December 7, 2017. acceptability of the exemption was Accession Nos. ML17061A747 and
determined in part by the acceptability ML17209A770, respectively) designated
Demetra Ashley,
of the amendment, the exemption and License Amendment Request (LAR) 17–
Acting Assistant Administrator.
amendment are being issued 006.
[FR Doc. 2017–26855 Filed 12–12–17; 8:45 am] concurrently. • NRC’s PDR: You may examine and
BILLING CODE 4410–09–P
DATES: The exemption and amendment purchase copies of public documents at
were issued on August 24, 2017. the NRC’s PDR, Room O1–F21, One
ADDRESSES: Please refer to Docket ID White Flint North, 11555 Rockville
NUCLEAR REGULATORY Pike, Rockville, Maryland 20852.
COMMISSION NRC–2008–0252 when contacting the
NRC about the availability of FOR FURTHER INFORMATION CONTACT:
[Docket Nos. 52–025 and 52–026; NRC– information regarding this document. William (Billy) Gleaves, Office of New
2008–0252] You may obtain publicly-available Reactors, U.S. Nuclear Regulatory
information related to this document Commission, Washington, DC 20555–
Southern Nuclear Operating Company, 0001; telephone: 301–415–5848; email:
using any of the following methods:
Inc., Vogtle Electric Generating Plant, • Federal Rulemaking website: Go to Bill.Gleaves@nrc.gov.
Units 3 and 4; Inspections, Tests, http://www.regulations.gov and search SUPPLEMENTARY INFORMATION:
Analyses, and Acceptance Criteria for Docket ID NRC–2008–0252. Address
Consolidation questions about NRC dockets to Carol I. Introduction
AGENCY: Nuclear Regulatory Gallagher; telephone: 301–415–3463; The NRC is granting an exemption
Commission. email: Carol.Gallagher@nrc.gov. For from paragraph B of section III, ‘‘Scope
ACTION: Exemption and combined technical questions, contact the and Contents,’’ of appendix D, ‘‘Design
license amendment; issuance. individual listed in the FOR FURTHER Certification Rule for the AP1000,’’ to
part 52 of title 10 of the Code of Federal
sradovich on DSK3GMQ082PROD with NOTICES
INFORMATION CONTACT section of this
SUMMARY: The U.S. Nuclear Regulatory document. Regulations (10 CFR), and issuing
Commission (NRC) is granting an • NRC’s Agencywide Documents License Amendment Nos. 85 and 84 to
exemption to allow a departure from Access and Management System COLs, NPF–91 and NPF–92,
elements of the certification information (ADAMS): You may obtain publicly- respectively, to the licensee. The
of Tier 1 of the generic AP1000 design available documents online in the exemption is required by paragraph A.4
control document (DCD) and is issuing ADAMS Public Documents collection at of section VIII, ‘‘Processes for Changes
License Amendment Nos. 85 and 84 to http://www.nrc.gov/reading-rm/ and Departures,’’ appendix D, to 10 CFR
VerDate Sep<11>2014 18:53 Dec 12, 2017 Jkt 244001 PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM 13DEN1](https://thefederalregister.org/doc/82_FR_58892/page/4.svg)
Document Created: 2017-12-13 01:23:50
Document Modified: 2017-12-13 01:23:50
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 12, 2018. Such persons may also file a written request for a hearing on the application on or before January 12, 2018. | |
| FR Citation | 82 FR 58654 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR